The COVID-19 pandemic has affected the health of people around the world in more than one way. The voices of medical personnel around the world have warned us relentlessly that decreased screening and early detection of cancer could have a devastating impact in the short term. In Costa Rica, the suspension of appointments and projects for early cancer care and detection added further imbalance to existing inequalities between populations and regions of the country.
Just how dire is that impact? What is the solution? What public-private partnerships are in place, or taking shape, that can reduce cancer mortality in Costa Rica?
This month, in “The Future of Cancer,” we’re diving deep into this topic. We’ll explore the experiences of patients and medical personnel around the country, and some of the various initiatives that have been developed to improve cancer prevention, diagnosis, and treatment. In our longform pieces, profiles, and columns, we’ll take a hard look at a medical system that has been put to the test like never before—and the potential that lies below the service.
Read the full issue here.
